JADENU®


Film-coated tablets
scheduling status
S4
registration number
50/27/0769; 50/27/0770
What JADENU® contains
JADENU 180 mg film-coated tablet contains 180 mg deferasirox JADENU 360 mg film-coated tablet contains 360 mg deferasirox.
other ingredients
Microcrystalline cellulose, crospovidone, povidone K30, magnesium stearate, colloidal silicon dioxide, poloxamer 188. Excipients of film-coating: Hypromellose, titanium dioxide (E 171), polyethylene glycol 4000, talc, FD&C blue #2/Indigo carminine aluminium lake (E132).
Therapeutic classification
V03AC03.
© 2026 SAHPRA. ALL RIGHTS RESERVED